CLNN
CLNN
NASDAQ · Biotechnology

Clene Inc

$6.16
-0.18 (-2.84%)
As of Jun 30, 10:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
259.4K
Net Income
-33,923,849
Gross Margin
78.5%
Profit Margin
-13,086.5%
Rev Growth
-24.8%
D/E Ratio
1.99
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 78.5% 78.5% 37.4% 37.4%
Operating Margin -11,541.5% -10,387.4% 12.4% 13.7%
Profit Margin -13,086.5% -12,432.2% 8.8% 10.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 259.4K 344.9K 28.89M 22.68M
Gross Profit 203.6K 270.7K 10.80M 8.48M
Operating Income -29,938,535 -35,821,166 3.57M 3.11M
Net Income -33,923,849 -40,589,556 2.55M 2.38M
Gross Margin 78.5% 78.5% 37.4% 37.4%
Operating Margin -11,541.5% -10,387.4% 12.4% 13.7%
Profit Margin -13,086.5% -12,432.2% 8.8% 10.5%
Rev Growth -24.8% -24.8% +0.1% +7.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 25.78M 25.78M 25.17M 22.41M
Total Equity 12.94M 12.94M 35.16M 34.69M
D/E Ratio 1.99 1.99 0.72 0.65
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -27,980,658 -35,338,507 4.88M 3.72M
Free Cash Flow 2.44M 2.81M